# Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

> **NCT04166474** · PHASE4 · COMPLETED · sponsor: **Helen Reynolds** · enrollment: 36 (actual)

## Conditions studied

- Hiv
- Tuberculosis

## Interventions

- **DRUG:** Dolutegravir

## Key facts

- **NCT ID:** NCT04166474
- **Lead sponsor:** Helen Reynolds
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-18
- **Primary completion:** 2024-02-07
- **Final completion:** 2024-02-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2024-08-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04166474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04166474, "Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04166474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*